Director/PDMR Shareholding

RNS Number : 6761S

Dechra Pharmaceuticals PLC

04 December 2012

 



Tuesday 4 December 2012

Dechra^® Pharmaceuticals PLC

("Dechra" or "the Company") 

(the Company)

PDMR Shareholding

The Company was informed on 4 December 2012 that Zoe Goulding, a PDMR of the Company, yesterday exercised SAYE options over 594 ordinary shares of 1p each ("Ordinary Shares") at an exercise price of £3.0492 per share.

Following this transaction, Zoe Goulding's beneficial interest stands at 7,182 Ordinary Shares, which represents approximately 0.008 per cent. of the Company's issued ordinary share capital.

Further enquiries:

Melanie Hall,  Assistant Company Secretary

00 44 1782 771100

About Dechra

Dechra is an international veterinary pharmaceutical business.  Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

RDSBKQDPCBDKCBK